| Date | Title | Description |
| 25.09.2025 | UberDoc Appoints Sean Kearney as CEO to Drive Next Phase of Growth and Innovation | UberDoc
New leadership to drive rapid growth as patients demand speed, transparency, and control in healthcare access.
BOSTON, Sept. 25, 2025 /PRNewswire-PRWeb/ -- UberDoc, an innovative healthcare platform empowering patients to connect wi... |
| 01.04.2025 | The Future of Genomic Insights: A New Era in Precision Medicine | In the realm of healthcare, data is the new gold. As we venture deeper into the age of precision medicine, the need for comprehensive genomic insights has never been more critical. Two companies, Genomize and Genomenon, are at the forefront... |
| 01.04.2025 | Genomenon Unlocks Real-World Evidence for Precision Therapeutics Developers | Genomenon logo
Novel AI solution extracts real-world insights from clinical literature to inform rare disease and cancer research
ANN ARBOR, Mich., April 1, 2025 /PRNewswire-PRWeb/ -- Genomenon, a leading provider of genomic intelligence, t... |
| 27.03.2025 | Genomize and Genomenon Partner to Empower Researchers and Clinicians with Comprehensive Genomic Insights | Genomenon and Genomize logos
Integration of Mastermind and Cancer Knowledgebase (CKB) Data To Drive Unprecedented Efficiency in Genomic Data Analysis
ISTANBUL and ANN ARBOR, Mich., March 27, 2025 /PRNewswire-PRWeb/ -- Genomize, a leader in ... |
| 06.03.2025 | Genomenon Advances Genomic Search on Mastermind with its New AI-Powered Integration | Genomenon logo
Unparalleled sensitivity of the platform now meets unmatched specificity - Mastermind Platform illustrates Genomenon's powerful combination of AI technology and human expertise
ANN ARBOR, Mich., March 6, 2025 /PRNewswire-PRWe... |
| 06.02.2025 | Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis | Genomenon logo
Data on CYP27A1 Variants Available to Genetic Testing Labs Around the World
ANN ARBOR, Mich., Feb. 6, 2025 /PRNewswire-PRWeb/ -- Genomenon, Inc., a leading provider of genomic intelligence solutions, has announced a strategic... |
| 17.12.2024 | Genomenon Applies Next-Generation AI to Create Searchable Knowledgebase of All Clinically-Relevant, Empirical Genomics Evidence | Genomenon logo
Genomenon Genomic Graph (G3) knowledgebase combines patient and biological data from nearly all published scientific and medical studies, including demographics, clinical characteristics, phenotypes, treatments, outcomes, and... |
| 06.11.2024 | SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research | SOPHiA GENETICS and GENOMENON
The companies expand partnership to enhance genetic variant interpretation for cancers and rare diseases
BOSTON and ROLLE, Switzerland , Nov. 6, 2024 /PRNewswire-PRWeb/ -- SOPHiA GENETICS (Nasdaq: SOPH), a clou... |
| 02.05.2024 | Genomenon Partners with Pharming to Advance APDS Diagnosis | Genomenon Logo
Genomenon Making Variant Data on the PIK3CD and PIK3R1 Genes Available to Genetic Testing Labs Across the World
ANN ARBOR, Mich., May 2, 2024 /PRNewswire-PRWeb/ -- Genomenon, a genomic intelligence company, has partnered with... |
| 14.03.2024 | Genomenon Presents Study Identifying 11,000 Gene Disease Relationships Across the Clinical Exome at the ACMG Annual Clinical Genetics Meeting | Genomenon, a leading genomic intelligence company
The 6-month study combined computational indexing of 9.5 million full-text genomic publications with a systematic literature review by genetic scientists
ANN ARBOR, Mich., March 14, 2024 /PR... |
| 27.06.2023 | Genomenon Acquires Boston Genetics to Accelerate Curation of Human Genome | "This acquisition builds on our success and puts us in the lead in the race to curate the entire human genome - bringing unprecedented actionable genomic insights for clinical diagnostic, newborn sequencing and drug development program... |
| 30.05.2023 | Genomenon Wins Best of Show Award at Bio-IT World 2023 Conference and Expo | This recognition aptly demonstrates how we enable pharmaceutical companies that are pioneering development of therapies for orphan diseases with Genomic Intelligence.
ANN ARBOR, Mich. (PRWEB) May 30, 2023
Genomenon Inc., a genomic intellige... |
| 08.05.2023 | Genomenon Recognized by Frost & Sullivan for Genomic Intelligence Solutions and Software for Pharma and Clinical Diagnostics Companies | Genomenon's unique blend of AI technology and expert scientific review delivers deep genomic insights into genetic drivers of rare diseases and cancer.
SAN ANTONIO, May 8, 2023 /PRNewswire/ -- Frost & Sullivan today announced that it ha... |
| 07.02.2023 | Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development | Flagship Biosciences' biomarker data services are critical to informing precision medicine decisions, and together with Genomenon's disease-specific genomic datasets powered by the Mastermind knowledgebase, the two companies provide unique ... |
| 10.01.2023 | Genomenon Recognized as Top Tech Company to Watch in 2023 by Purpose Jobs | "The founders and teams running these Tech Companies to Watch deserve kudos for all of their incredibly hard work.” – Ryan Landau, founder and CEO, Purpose Jobs
ANN ARBOR, Mich. (PRWEB) January 10, 2023
Genomenon Inc., an AI-driven gen... |
| 05.01.2023 | Genomenon to Participate in BIO Partnering at JPM During J.P. Morgan Week 2023 | ANN ARBOR, Mich. (PRWEB) January 05, 2023
Genomenon, Inc., an AI-driven genomics company, announced today that it will participate in BIO Partnering at JPM, January 9-12, 2023 in San Francisco.
Details of the event are as follows:
Event: BI... |
| 29.11.2022 | Genomenon Partners with Three Rare Disease Foundations to Advance Precision Drug Development | “Our collaboration with Genomenon represents a big step toward finding a cure for genetic developmental disorders." –Dr. Terry Jo Bichell, Founder, COMBINEDBrain
ANN ARBOR, Mich. (PRWEB) November 29, 2022
Genomenon Inc., an AI-driven g... |
| 15.11.2022 | Genomenon Provides Genomic Data on 450 Diseases to Advance Early Identification of Rare Disease in Newborns | “Genomenon’s essential role in curating actionable genomic information and making it easily accessible...is critical to making newborn screening for a broad set of rare diseases a reality.” – Dr. Stephen Kingsmore, President & CEO, Rady... |
| 31.10.2022 | New Study Presents Novel Solution to Increasing Diagnostic Yield and Accelerating Diagnosis of Rare Disease | "Our partnership with Inozyme puts critical information about ENPP1 Deficiency at the fingertips of doctors...and will play a key role in addressing missed diagnoses, which has long been a challenge for this disease community.” – Dr. M... |
| 13.09.2022 | Genomenon Appoints Vice President of Operations to Leadership Team | "Joining the team that is transforming how genomic information is made actionable for patients and drug development is very exciting—I look forward to helping accelerate the future of precision medicine that Genomenon is playing a role... |
| 07.09.2022 | Genomenon Integrates ClinVar Data into Mastermind to Support Clinical Decision-Making | "With the most comprehensive source of genomic information at their fingertips, Mastermind users will be able to quickly view the evidence needed to make a genetic diagnosis and provide a path forward for patients."—Mike Klein, CE... |
| 07.09.2022 | Genomenon Integrates ClinVar Data into Mastermind to Support Clinical Decision-Making | Patient Variant Information Submitted to NIH Now Accessible Through Mastermind Genomic Search Engine
ANN ARBOR, Mich., Sept. 7, 2022 /PRNewswire-PRWeb/ -- Genomenon, Inc., an AI-driven genomics company, has integrated all the variants and p... |
| 02.08.2022 | Genomenon Partners with Rady Children’s Institute for Genomic Medicine on Newborn Screening by Next Generation Sequencing | “Genomenon’s essential role in curating actionable genomic information and making it easily accessible to these professionals is helping transform [our] goal into a reality.” – Dr. Stephen Kingsmore, President & CEO, Rady Children's Ins... |
| 09.06.2022 | Genomenon to Present at the 2022 BIO International Convention | ANN ARBOR, Mich. (PRWEB) June 09, 2022
Genomenon, Inc., an AI-driven genomics company, today announced that their Chief Scientific Officer, Mark Kiel, MD, PhD, will present on Monday, June 13, 2022 at 3:15 PM PT at the 2022 BIO Internationa... |
| 07.06.2022 | Genomenon and Agilent Partner to Improve Genomic Variant Interpretation | “Leveraging Mastermind to enhance the unique collection of curated knowledge sources of Alissa Interpret strengthens our position in the somatic and hereditary disease markets.” – Kevin Meldrum, VP and GM of the Integrated Genomics Division... |
| 13.03.2022 | Genomenon raises $20M Series B Financing led by Spring Mountain Capital and Beringea | - |
| 10.03.2022 | Genomenon raises $20 million Series B Financing led by Spring Mountain Capital and Beringea | - |
| 10.03.2022 | Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data | "...Genomenon’s AI driven technology platform is the ideal solution to bring life changing therapies to patients while enabling Pharma to more efficiently discover and develop new targeted therapies." –Michael Gross, Managing Dire... |
| 22.02.2022 | Genomenon Partners with Don’t Forget Morgan to Provide New Hope for Rare Disease | "We are thankful for the partnership with Genomenon and the support they will provide as we search for a treatment and cure for all children suffering with BPAN." –Kelly Kozole, Executive Director, Don’t Forget Morgan
ANN ARBOR, M... |
| 15.02.2022 | Genomenon Awarded NIH NHGRI Grant to Curate the Human Genome | "Curating the entire genome for meaning and actionability at scale is the next step in the evolution of using [genomic] information to improve patient care.” –Mike Klein, CEO, Genomenon
ANN ARBOR, Mich. (PRWEB) February 15, 2022
Genome... |
| 20.01.2022 | Genomenon Appoints New Chief Financial Officer to Leadership Team | “I am humbled and honored to begin the next chapter of my professional career with a company that has its sights set on life-changing work in genomics.” – Sean Kearney, CFO, Genomenon
ANN ARBOR, Mich. (PRWEB) January 20, 2022
Following a ye... |
| 04.01.2022 | Genomenon and OmniTier Partner to Bring Mastermind’s Evidence Sources to CompStor Insight | With this partnership, we will bring the power of Mastermind variant evidence lookup to CompStor’s fast, low cost, on-premises based variant interpretation, designed to expand genomic screening at an affordable cost.”
ANN ARBOR, Mich. (PRWE... |
| 30.11.2021 | Genomenon Extends Insight into Genomic Evidence with Mastermind Search Companion | "Genomenon’s Search Companion extends Mastermind’s support into additional variant databases for everyone tasked with interpreting genomic data" – Mike Klein, Genomenon
ANN ARBOR, Mich. (PRWEB) November 30, 2021
Genomenon, Inc., a... |
| 11.11.2021 | Genomenon and Inozyme Pharma Announce Partnership to Advance Genetic Diagnosis for Rare Disease Patients | “Genomenon’s AI-driven data has the potential to greatly increase our collective understanding of ENPP1 Deficiency.” – Axel Bolte, Inozyme Pharma
ANN ARBOR, Mich. (PRWEB) November 11, 2021
Genomenon, Inc.®, an AI-driven genomics company, an... |
| 04.11.2021 | Genomenon and Deep 6 AI Sign Proof of Concept Agreement to Increase Clinical Trial Matching Capabilities | "Together, both Genomenon and Deep 6 AI will provide a combined, AI-driven understanding of disease, enabling actionable insight into their genetic drivers, clinical representation, and comorbidity." –Jason Attanucci, Deep 6 AI
AN... |
| 20.09.2021 | Genomenon Announces Collaboration to Accelerate Genetic Diagnosis for Rare Disease Patients | “We are encouraged by our collaboration with Genomenon and the potential to advance our collective efforts to enable earlier diagnosis and treatment for people living with rare diseases.”
ANN ARBOR, Mich. (PRWEB) September 20, 2021
Genomeno... |
| 01.06.2021 | Genomenon and Nostos Genomics Partner to Accelerate Rare Genetic Disease Diagnoses | "This collaboration stemmed from a shared desire to not only provide clinicians with the best decision support possible, but also improve the accuracy, speed, and accessibility of genetic testing to lessen the burden of the diagnostic ... |
| 20.05.2021 | Genomenon Publishes Key Findings from the Genomic Landscape for ALS | “By leveraging a unique combination of AI and scientific review, our team has been able to curate the first genomic landscapes for neurodegenerative diseases at a pace and level of comprehensiveness never before achieved.”
ANN ARBOR, Mich. ... |
| 12.04.2021 | Genomenon and Limbus Partner to Advance Genomic Variant Interpretation | "[Mastermind] brings the most rapidly growing collection of scientific genomic literature into the patient-centered varvis cockpit so that the clinician can view all relevant information for this specific patient at a glance.”
ANN ARBO... |
| 26.01.2021 | Genomenon Announces Publication of Scientific Paper in Frontiers in Genetics | “This is just the first chapter in our journey to save and improve lives by making genomic information actionable.” Mark Kiel, MD, PhD. Co-Founder, Genomenon
ANN ARBOR, Mich. (PRWEB) January 26, 2021
Genomenon, Inc., an AI-driven genomics c... |
| 03.10.2019 | Congenica integrates powerful new curated data | Congenica integrates powerful new curated data
03-10-2019
Congenica Ltd, a digital health technology company enabling accelerated interpretation of complex genomic data to improve disease diagnosis, has announced significant developments to... |
| 08.02.2019 | Genomenon Raises $2.5M, Plans to Increase Work with Pharma Customers | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Genomenon, the Ann Arbor, MI-based genomics search engine startup, has raised $2.5 million in what the company calls a “seed extension” round.
The equity financing included in... |
| 01.04.2016 | Genomenon, SPLT, Entrocim Compete to Pitch at Google Demo Day in CA | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Three Detroit-area startups are vying for a spot in a national pitch contest at Google’s California headquarters, after winning the third annual Google Demo Day held in downto... |
| 27.01.2015 | LevelEleven, AdAdapted, and Genomenon Win Google’s Detroit Demo Day | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Three Detroit-area startups will vie for a spot in a pitch contest at Google’s California headquarters this spring, after winning the second annual Google Demo Day in downtown... |
| - | Genomenon | “Genomenon transforms complex genetic data into actionable insights. Explore software for clinical diagnostics and solutions for drug R&D” |
